These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


104 related items for PubMed ID: 33116040

  • 1. Therapeutic potential of Chinese prescription Kangen-karyu for patient with lifestyle-induced metabolic syndrome.
    Park CH, Kitazawa T, Futamura A, Hirana H, Shoji M, Osanai M, Yokozawa T.
    Drug Discov Ther; 2020 Nov 04; 14(5):252-255. PubMed ID: 33116040
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The protective role of Chinese prescription Kangen-karyu extract on diet-induced hypercholesterolemia in rats.
    Yokozawa T, Cho EJ, Sasaki S, Satoh A, Okamoto T, Sei Y.
    Biol Pharm Bull; 2006 Apr 04; 29(4):760-5. PubMed ID: 16595914
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of Chinese prescription Kangen-karyu on lipid metabolism in type 2 diabetic db/db mice.
    Yamabe N, Kim HY, Kang KS, Zhao Q, Matsumoto K, Yokozawa T.
    J Ethnopharmacol; 2010 Jun 16; 129(3):299-305. PubMed ID: 20363309
    [Abstract] [Full Text] [Related]

  • 7. Protective effect of Chinese prescription Kangen-karyu and its crude drug Tanjin against age-related lipidosis in rats.
    Cho EJ, Yokozawa T, Okamoto T.
    J Pharm Pharmacol; 2007 May 16; 59(5):687-94. PubMed ID: 17524234
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic effect of Chinese prescription Kangen-karyu in patients with diabetic nephropathy.
    Park CH, Hiratani K, Natazuka T, Yokozawa T.
    Drug Discov Ther; 2020 May 16; 14(2):84-88. PubMed ID: 32378650
    [Abstract] [Full Text] [Related]

  • 9. Antioxidative effects related to the potential anti-aging properties of the Chinese prescription Kangen-karyu and Carthami Flos in senescence-accelerated mice.
    Satoh A, Yokozawa T, Cho EJ, Okamoto T, Sei Y.
    Arch Gerontol Geriatr; 2004 May 16; 39(1):69-82. PubMed ID: 15158582
    [Abstract] [Full Text] [Related]

  • 10. Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats.
    Kim HY, Okamoto T, Yokozawa T.
    J Ethnopharmacol; 2009 Jul 15; 124(2):263-9. PubMed ID: 19397970
    [Abstract] [Full Text] [Related]

  • 11. The mechanisms underlying the anti-aging activity of the Chinese prescription Kangen-karyu in hydrogen peroxide-induced human fibroblasts.
    Satoh A, Yokozawa T, Kim YA, Cho EJ, Okamoto T, Sei Y.
    J Pharm Pharmacol; 2005 Oct 15; 57(10):1335-43. PubMed ID: 16259763
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepato-/reno-protective activity of Chinese prescription Kangen-karyu through inhibition of AGE formation and fibrosis-related protein expression in type 2 diabetes.
    Okamoto T, Park CH, Noh JS, Toriizuka K, Sei Y, Park JC, Yokozawa T.
    J Pharm Pharmacol; 2011 Jul 15; 63(7):952-9. PubMed ID: 21635261
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of Chinese prescription Kangen-karyu for dyslipi-demia, using 3T3-L1 adipocytes and type 2 diabetic mice.
    Hum Park C, Young Rhyu D, Sook Noh J, Min Park C, Yokozawa T.
    Drug Discov Ther; 2014 Jun 15; 8(3):121-31. PubMed ID: 25031044
    [Abstract] [Full Text] [Related]

  • 15. Chinese prescription kangen-karyu ameliorates the development of diabetic hepatic damages via regulating oxidative stress and inflammation in the liver of db/db mice.
    Park CH, Yamabe N, Okamoto T, Toriizuka K, Yokozawa T.
    Biol Pharm Bull; 2011 Jun 15; 34(3):383-8. PubMed ID: 21372389
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic efficacy of Kangen-karyu against H2O2-induced premature senescence.
    Cho EJ, Okamoto T, Yokozawa T.
    J Pharm Pharmacol; 2008 Nov 15; 60(11):1537-44. PubMed ID: 18957176
    [Abstract] [Full Text] [Related]

  • 18. Protective effect of the Chinese prescription Kangen-karyu against high glucose-induced oxidative stress in LLC-PK1 cells.
    Yokozawa T, Kim YA, Kim HY, Okamoto T, Sei Y.
    J Ethnopharmacol; 2007 Jan 03; 109(1):113-20. PubMed ID: 16949779
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of Effects of Chinese Prescription Kangen-karyu on Diabetes-Induced Alterations such as Oxidative Stress and Apoptosis in the Liver of Type 2 Diabetic db/db Mice.
    Park CH, Noh JS, Okamoto T, Park JC, Yokozawa T.
    Evid Based Complement Alternat Med; 2012 Jan 03; 2012():143489. PubMed ID: 22969821
    [Abstract] [Full Text] [Related]

  • 20. Kangen-karyu raises surface body temperature through oxidative stress modification.
    Hirayama A, Okamoto T, Kimura S, Nagano Y, Matsui H, Tomita T, Oowada S, Aoyagi K.
    J Clin Biochem Nutr; 2016 May 03; 58(3):167-73. PubMed ID: 27257340
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.